Increased Muscle Sympathetic Nerve Activity and Impaired Executive Performance Capacity in Obstructive Sleep Apnea

Carregando...
Imagem de Miniatura
Citações na Scopus
32
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER ACAD SLEEP MEDICINE
Citação
SLEEP, v.39, n.1, p.25-33, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Study Objectives: To investigate muscle sympathetic nerve activity (MSNA) response and executive performance during mental stress in obstructive sleep apnea (OSA). Methods: Individuals with no other comorbidities (age = 52 +/- 1 y, body mass index = 29 +/- 0.4, kg/m(2)) were divided into two groups: (1) control (n = 15) and (2) untreated OSA (n = 20) defined by polysomnography. Mini-Mental State of Examination (MMSE) and Inteligence quocient (IQ) were assessed. Heart rate (HR), blood pressure (BP), and MSNA (microneurography) were measured at baseline and during 3 min of the Stroop Color Word Test (SCWT). Sustained attention and inhibitory control were assessed by the number of correct answers and errors during SCWT. Results: Control and OSA groups (apnea-hypopnea index, AHI = 8 +/- 1 and 47 +/- 1 events/h, respectively) were similar in age, MMSE, and IQ. Baseline HR and BP were similar and increased similarly during SCWT in control and OSA groups. In contrast, baseline MSNA was higher in OSA compared to controls. Moreover, MSNA significantly increased in the third minute of SCWT in OSA, but remained unchanged in controls (P < 0.05). The number of correct answers was lower and the number of errors was significantly higher during the second and third minutes of SCWT in the OSA group (P < 0.05). There was a significant correlation (P < 0.01) between the number of errors in the third minute of SCWT with AHI (r = 0.59), arousal index (r = 0.55), and minimum O-2 saturation (r = -0.57). Conclusions: As compared to controls, MSNA is increased in patients with OSA at rest, and further significant MSNA increments and worse executive performance are seen during mental stress.
Palavras-chave
executive performance, mental stress, muscle sympathetic nerve activity, obstructive sleep apnea
Referências
  1. Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552
  2. Lundblad LC, 2014, NEUROIMAGE, V103, P258, DOI 10.1016/j.neuroimage.2014.09.031
  3. Ribeiro MM, 2005, CIRCULATION, V111, P1915, DOI 10.1161/01.CIR.0000161959.04675.5A
  4. Ip MSM, 2004, AM J RESP CRIT CARE, V169, P348, DOI 10.1164/rccm.200306.767OC
  5. Roveda F, 2003, J AM COLL CARDIOL, V42, P854, DOI 10.1016/S0735-1097(03)00831-3
  6. Macey PM, 2008, SLEEP, V31, P967
  7. Kuniyoshi FHS, 2003, OBES RES, V11, P1411, DOI 10.1038/oby.2003.190
  8. Seematter G, 2000, AM J PHYSIOL-ENDOC M, V279, pE799
  9. Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223
  10. Garner JK, 2009, J PSYCHOL, V143, P405, DOI 10.3200/JRLP.143.4.405-426
  11. CALLISTER R, 1992, J PHYSIOL-LONDON, V454, P373
  12. CARLSON JT, 1993, CHEST, V103, P1763, DOI 10.1378/chest.103.6.1763
  13. Tonacio AC, 2006, BRAZ J MED BIOL RES, V39, P53, DOI 10.1590/S0100-879X2006000100006
  14. Durocher JJ, 2011, AM J PHYSIOL-HEART C, V300, pH1788, DOI 10.1152/ajpheart.00942.2010
  15. Middlekauff HR, 1997, CIRCULATION, V96, P1835
  16. Morgan BJ, 1996, SLEEP, V19, pS206
  17. Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008
  18. Narkiewicz K, 2003, ACTA PHYSIOL SCAND, V177, P385, DOI 10.1046/j.1365-201X.2003.01091.x
  19. Drager LF, 2010, CURR OPIN ENDOCRINOL, V17, P161, DOI 10.1097/MED.0b013e3283373624
  20. Chida Y, 2010, HYPERTENSION, V55, P1026, DOI 10.1161/HYPERTENSIONAHA.109.146621
  21. Henderson LA, 2003, J APPL PHYSIOL, V94, P1063, DOI 10.1152/japplphysiol.00702.2002
  22. Smith ML, 1996, J AUTONOM NERV SYST, V56, P184, DOI 10.1016/0165-1838(95)00062-3
  23. Beebe DW, 2003, SLEEP, V26, P298
  24. Carter JR, 2005, J PHYSIOL-LONDON, V564, P321, DOI 10.1113/jphysiol.2004.079665
  25. STOOHS RA, 1995, CHEST, V107, P1275, DOI 10.1378/chest.107.5.1275
  26. Sagaspe P, 2007, J SLEEP RES, V16, P381, DOI 10.1111/j.1365-2869.2007.00607.x
  27. James C, 2013, NEUROIMAGE, V70, P59, DOI [10.1016/j.neuroimage.2012.12.047, 10.1016/j.neuroimage.012.12.047]
  28. Carvalheira JBC, 2005, OBES RES, V13, P48, DOI 10.1038/oby.2005.7
  29. BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893
  30. Abboud F, 2014, J CLIN INVEST, V124, P1454, DOI 10.1172/JCI70420
  31. Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7
  32. Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115
  33. Hassing LB, 2010, DEMENT GERIATR COGN, V29, P543, DOI 10.1159/000314874
  34. Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5
  35. Narkiewicz K, 1997, J HYPERTENS, V15, P1613, DOI 10.1097/00004872-199715120-00062
  36. Jelic S, 2008, CIRCULATION, V117, P2270, DOI 10.1161/CIRCULATIONAHA.107.741512
  37. Lau EYY, 2010, J INT NEUROPSYCH SOC, V16, P1077, DOI 10.1017/S1355617710000901
  38. JOHNS MW, 1991, SLEEP, V14, P540
  39. Jelic S, 2010, CIRCULATION, V121, P1014, DOI 10.1161/CIRCULATIONAHA.109.900357
  40. SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502
  41. [Anonymous], 1975, J PSYCHIATR RES, DOI 10.1016/0022-3956(75)90026-6
  42. Drager LF, 2009, J HYPERTENS, V27, P1655, DOI 10.1097/HJH.0b013e32832c6982
  43. Garcia CEV, 2013, AM J HYPERTENS, V26, P617, DOI 10.1093/ajh/hps065
  44. Ueno LM, 2009, SLEEP, V32, P637
  45. FINDLEY LJ, 1988, AM REV RESPIR DIS, V138, P337
  46. Schwartz CE, 2011, J APPL PHYSIOL, V110, P76, DOI 10.1152/japplphysiol.00912.2010
  47. Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022
  48. Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011
  49. Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002
  50. Atkeson Amy, 2008, Vasc Health Risk Manag, V4, P1327
  51. Badrov MB, 2015, AM J PHYSIOL-REG I, V309, pR160, DOI 10.1152/ajpregu.00077.2015
  52. BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561
  53. Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500
  54. Fatouleh RH, 2014, NEUROIMAGE-CLIN, V27, P275
  55. JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7
  56. Kingshott Ruth N, 2004, Sleep Breath, V8, P61, DOI 10.1055/s-2004-829636
  57. Macey PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076631
  58. Naegele B, 1995, SLEEP, V18, P43
  59. Perusse-Lachance E, 2012, BIOENERGETICS, V2, P107
  60. Toschi-Dias E, 2013, AM J PHYSIOL-HEART C, V304, pH1038, DOI 10.1152/ajpheart.00848.2012
  61. Wechsler D., 1999, WECHSLER ABBREVIATED
  62. BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095